Targeting MAPK4 emerges as a promising therapy for prostate cancer

Retrieved on: 2021-02-19 19:52:30

Tags for this article:

Branches of biology

Signal transduction

PI3K/AKT/mTOR pathway

MTOR inhibitors

Click the tags to see associated articles and topics

Targeting MAPK4 emerges as a promising therapy for prostate cancer. View article details on hiswai:

Excerpt

Research led by Baylor College of Medicine reveals in the Journal of ... "One complication with targeting AR (for instance, with medical castration ...

Article found on: www.eurekalert.org

View Original Article